Nexien BioPharma, Inc.

OTCPK:NXEN Stock Report

Market Cap: US$920.0k

Nexien BioPharma Ownership

Who are the major shareholders and have insiders been buying or selling?


Recent Insider Transactions

Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.


Ownership Breakdown

What is the ownership structure of NXEN?
Owner TypeNumber of SharesOwnership Percentage
VC/PE Firms5,000,0007.06%
Private Companies19,000,00026.8%
Individual Insiders20,505,49329%
General Public26,266,70337.1%

Dilution of Shares: Shareholders have been diluted in the past year, with total shares outstanding growing by 8.4%.


Top Shareholders

Top 7 shareholders own 62.89% of the company
OwnershipNameSharesCurrent ValueChange %Portfolio %
26.9%
INTIVA Inc.
19,000,000US$247.0k0%no data
10.2%
Richard Greenberg
7,185,193US$93.4k0%no data
9.18%
Evan Wasoff
6,500,000US$84.5k0%no data
7.06%
Kanativa Inc.
5,000,000US$65.0k0%no data
5.39%
Alexander Wasyl
3,811,500US$49.5k0%no data
3.22%
Robert Goldfarb
2,278,800US$29.6k0%no data
1.03%
Lindy Snider
730,000US$9.5k0%no data